BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 21862942)

  • 1. Selective approach to radionuclide-guided sentinel lymph node biopsy in high-risk ductal carcinoma in situ of the breast.
    Usmani S; Khan HA; Al Saleh N; abu Huda F; Marafi F; Amanguno HG; Al Nafisi N; Al Kandari F
    Nucl Med Commun; 2011 Nov; 32(11):1084-7. PubMed ID: 21862942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of radiocolloid preference on major parameters in sentinel lymph node biopsy practice in breast cancer.
    Yararbas U; Argon AM; Yeniay L; Zengel B; Kapkaç M
    Nucl Med Biol; 2010 Oct; 37(7):805-10. PubMed ID: 20870155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin.
    Tsugawa K; Noguchi M; Miwa K; Bando E; Yokoyama K; Nakajima K; Michigishi T; Tonami N; Minato H; Nonomura A
    Breast Cancer; 2000 Jan; 7(1):87-94. PubMed ID: 11029778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of sentinel lymph node biopsy in ductal carcinoma in situ (DCIS) and DCIS with microinvasion of the breast.
    van la Parra RF; Ernst MF; Barneveld PC; Broekman JM; Rutten MJ; Bosscha K
    Eur J Surg Oncol; 2008 Jun; 34(6):631-5. PubMed ID: 17851019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of the lymphoscintigraphy in the evaluation of non-axillary sentinel lymph node localization in breast cancer.
    Gherghe M; Bordea C; Blidaru A
    Chirurgia (Bucur); 2015; 110(1):26-32. PubMed ID: 25800312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.
    Moore KH; Sweeney KJ; Wilson ME; Goldberg JI; Buchanan CL; Tan LK; Liberman L; Turner RR; Lagios MD; Cody Iii HS; Giuliano AE; Silverstein MJ; Van Zee KJ
    Ann Surg Oncol; 2007 Oct; 14(10):2911-7. PubMed ID: 17597346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ductal carcinoma in situ: value of sentinel lymph node biopsy.
    Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S
    J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy.
    Mittendorf EA; Arciero CA; Gutchell V; Hooke J; Shriver CD
    Curr Surg; 2005; 62(2):253-7. PubMed ID: 15796952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy.
    van Roozendaal LM; Goorts B; Klinkert M; Keymeulen KBMI; De Vries B; Strobbe LJA; Wauters CAP; van Riet YE; Degreef E; Rutgers EJT; Wesseling J; Smidt ML
    Breast Cancer Res Treat; 2016 Apr; 156(3):517-525. PubMed ID: 27083179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simplified technique of radioguided occult lesion localization (ROLL) plus sentinel lymph node biopsy (SNOLL) in breast carcinoma.
    Lavoué V; Nos C; Clough KB; Baghaie F; Zerbib E; Poulet B; Lefrère Belda MA; Ducellier A; Lecuru F
    Ann Surg Oncol; 2008 Sep; 15(9):2556-61. PubMed ID: 18574635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel lymph node biopsy for ductal carcinoma in situ: an evolving approach at the University of Florida.
    Camp R; Feezor R; Kasraeian A; Cendan J; Schell S; Wilkinson E; Copeland E; Lind S
    Breast J; 2005; 11(6):394-7. PubMed ID: 16297082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel lymph node biopsy is not necessary in patients diagnosed with ductal carcinoma in situ of the breast by stereotactic vacuum-assisted biopsy.
    Kotani H; Yoshimura A; Adachi Y; Ishiguro J; Hisada T; Ichikawa M; Gondou N; Hattori M; Kondou N; Sawaki M; Fujita T; Iwata H
    Breast Cancer; 2016 Mar; 23(2):190-4. PubMed ID: 24989112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast lymphoscintigraphy for sentinel node identification in breast cancers with clinically-negative axillary nodes.
    Namwongprom S; Boonyaprapa S; Ekmahachai M; Vilasdechanon N; Somwangprasert A; Sumitsawan S; Taya P
    Singapore Med J; 2005 Dec; 46(12):688-92. PubMed ID: 16308641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of treatment with mastectomy, use of sentinel lymph node biopsy and upstaging to invasive cancer in patients diagnosed with breast ductal carcinoma in situ (DCIS) on core biopsy.
    Chin-Lenn L; Mack LA; Temple W; Cherniak W; Quinn RR; Ravani P; Lewin AM; Quan ML
    Ann Surg Oncol; 2014 Jan; 21(1):66-73. PubMed ID: 24046105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel lymph node scintigraphy and radioguided dissection in breast carcinoma: an initial experience at Aga Khan University Hospital.
    Zaman MU; Khan S; Hussain R; Ahmed MN
    J Pak Med Assoc; 2006 Apr; 56(4):153-6. PubMed ID: 16711334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion?
    Klauber-DeMore N; Tan LK; Liberman L; Kaptain S; Fey J; Borgen P; Heerdt A; Montgomery L; Paglia M; Petrek JA; Cody HS; Van Zee KJ
    Ann Surg Oncol; 2000 Oct; 7(9):636-42. PubMed ID: 11034239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of invasion and axillary lymph node metastasis in patients with a core biopsy diagnosis of ductal carcinoma in situ: an analysis of 255 cases.
    Han JS; Molberg KH; Sarode V
    Breast J; 2011; 17(3):223-9. PubMed ID: 21545433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel lymph node biopsy in patients with operable breast cancer treated with neoadjuvant chemotherapy.
    Rebollo-Aguirre AC; Gallego-Peinado M; Menjón-Beltrán S; García-García J; Pastor-Pons E; Chamorro-Santos CE; Ramos-Font C; Salamanca-Ballesteros A; Llamas-Elvira JM; Olea-Serrano N
    Rev Esp Med Nucl Imagen Mol; 2012; 31(3):117-23. PubMed ID: 21676504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of the European institute of oncology on 854 patients in 10 years.
    Intra M; Rotmensz N; Veronesi P; Colleoni M; Iodice S; Paganelli G; Viale G; Veronesi U
    Ann Surg; 2008 Feb; 247(2):315-9. PubMed ID: 18216539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of intraoperative frozen section examination of sentinel lymph nodes in ductal carcinoma in situ of the breast.
    Ballehaninna UK; Chamberlain RS
    Clin Breast Cancer; 2013 Oct; 13(5):350-8. PubMed ID: 23791128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.